BANK OF AMERICA CORP /DE/
BankPosition in NAUT — Nautilus Biotechnology, Inc.
CIK 70858
CHARLOTTE, NC
Position in NAUT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$144,098
-$100,912 QoQ
Shares Held
77,058
+22.0% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 93 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. NAUT ranks #299 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in NAUT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,098 | 77,058 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $245,010 | 63,147 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $39,324 | 20,167 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $6,063 | 8,363 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,529 | 29,652 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $83,023 | 49,419 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $102,759 | 36,056 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $62,496 | 26,708 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $28,561 | 9,715 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $126,231 | 42,218 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $115,661 | 36,602 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $135,937 | 35,126 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $99,742 | 36,008 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $72,323 | 40,180 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $71,680 | 33,812 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $100,369 | 37,312 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $333,011 | 76,731 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,512 | 4,153 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $132,629 | 21,601 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||